Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CS-917 Monotherapy in Type 2 Diabetes
NCT00290940Phase 2Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jan 2006
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of managlinat dialanetil in type 2 diabetes mellitus (T2DM), sponsored by Daiichi Sankyo Co., Ltd.. Started Jan 2006; status: completed.
02
Drugs
managlinat dialanetil
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00290940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00290940.